Christina M. Woo was born (1986) in New York. She obtained a BA in Chemistry from Wellesley College (2008) and conducted undergraduate research in the laboratory of Professor Dora Carrico-Moniz. She obtained her PhD in 2013 from Yale University. Under the guidance of Professor Seth B. Herzon, she completed syntheses of the diazofluorene antitumor antibiotics (–)-kinamycin F and (–)-lomaiviticin aglycon, the semisynthesis of (–)-lomaiviticin A, and conducted mechanism of action studies to uncover the relationship between diazofluorene structure and DNA binding and damaging activity. In 2013, Christina joined the laboratory of Professor Carolyn R. Bertozzi at the University of California Berkeley as a Jane Coffins Child postdoctoral fellow, and continued at Stanford University in 2015 as a Burroughs Wellcome Fund CASI Fellow, where she developed a mass independent chemical glycoproteomics platform. Christina joined the Department of Chemistry and Chemical Biology at Harvard University as an Assistant Professor in July, 2016.
Honors and Awards
Burroughs Wellcome Fund, Career Awards at the Scientific Interface Fellow (2015–2020), Stanford University Mass Spectrometry Seed Grant (2015–2016), Best Presentation Award, Stanford CHEM-H Postdoc Retreat (2015), Richard Wolfgang Prize for Best Dissertation in Chemistry (2014), Howard Hughes Medical Institute Fellow of the Jane Coffin Childs Memorial Fund (2013–2016), Roche Excellence in Chemistry Award (2012), Sigma-Aldrich Graduate Student Innovation Award (2011), National Science Foundation Graduate Research Fellowship (2010–2013), Dox Graduate Summer Fellowship (2009), Sigma-Xi Inductee (2008), Honorable mention, Merck Index Women in Chemistry Scholarship (2008), NSF Research Experience for Undergraduates Grant Recipient (2006), DAAD Research Internships in Science and Engineering Scholarship (2005)